We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust ...

Q4 2024 Earnings Call Transcript March 6, 2025 Arcturus Therapeutics Holdings Inc. misses on earnings expectations. Reported ...

InTandem Capital Partners ("InTandem Capital" or the "Firm"), a healthcare services-focused private equity firm, announced today that it has partnered with the founder and management team at Clinilabs ...

However, I am happy to report that based on the current pipeline and program, the cash runway will remain strong and is expected to extend until the end of the first quarter of 2027. In summary ...

Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today publishes the year-end report for 2024. "Pepaxti sales increased about 35 percent ...

The report of the inspection results by the Federation of Pharmaceutical Manufacturers' Associations of Japan can be found at the link below. Results of voluntary inspections regarding consistency ...

Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong Joenja® (leniolisib) growth Fourth quarter 2024 total revenu ...

I'm very pleased to report that 2024 was another record year ... and we expect to have substantive discussions with PMDA by mid-2025. Turning to slide 15. I'll review the unique clinical profile ...

The RECELL System, excluding RECELL GO®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval ... for our authors to report on investments fairly ...